Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

Le Houezec J, Aubin HJ.

Expert Opin Pharmacother. 2013 Oct;14(14):1959-67. doi: 10.1517/14656566.2013.818978. Epub 2013 Aug 26. Review.

PMID:
23978314
2.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
4.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
5.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
6.

Pharmacotherapy for smoking cessation: present and future.

Aubin HJ, Karila L, Reynaud M.

Curr Pharm Des. 2011;17(14):1343-50. Review.

PMID:
21524268
7.

Emerging drugs for the treatment of tobacco dependence: 2014 update.

Elrashidi MY, Ebbert JO.

Expert Opin Emerg Drugs. 2014 Jun;19(2):243-60. doi: 10.1517/14728214.2014.899580. Epub 2014 Mar 22. Review.

PMID:
24654737
8.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Hays JT, Ebbert JO.

Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Review.

PMID:
21142259
9.

Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Aubin HJ, Luquiens A, Berlin I.

Br J Clin Pharmacol. 2014 Feb;77(2):324-36. doi: 10.1111/bcp.12116. Review.

10.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
11.

Strategies to help a smoker who is struggling to quit.

Rigotti NA.

JAMA. 2012 Oct 17;308(15):1573-80. doi: 10.1001/jama.2012.13043.

12.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
13.
14.

Non-nicotinic therapies for smoking cessation.

Siu EC, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2007;47:541-64. Review.

PMID:
17209799
15.
16.

Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.

Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T.

Addiction. 2014 Sep;109(9):1414-25. doi: 10.1111/add.12633. Epub 2014 Jul 4. Review.

PMID:
24995905
17.

Nicotine dependence and smoking cessation.

Tan L, Tang Q, Hao W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Nov;34(11):1049-57. Review.

18.

Smoking cessation.

Rennard SI, Daughton DM.

Clin Chest Med. 2014 Mar;35(1):165-76. doi: 10.1016/j.ccm.2013.11.002. Review.

PMID:
24507844
19.

Tobacco smoking: options for helping smokers to quit.

Zwar NA, Mendelsohn CP, Richmond RL.

Aust Fam Physician. 2014 Jun;43(6):348-54.

20.

Tobacco smoking cessation management: integrating varenicline in current practice.

Galanti LM.

Vasc Health Risk Manag. 2008;4(4):837-45. Review.

Supplemental Content

Support Center